Nabila Nur Kamelia

Stability Study Analyst at COMBIPHAR

Nabila Nur Kamelia currently serves as a Stability Study Analyst at COMBIPHAR since July 2022. In parallel, Nabila has been an Influencer for Komisi Penanggulangan AIDS Kota Bandung since November 2020. Previous experience includes roles as a Laboratory Analyst at PT. Cipta Aneka Pangan Prima and as a Puteri Bahari Jawa Barat 2022 with Dinas Kelautan dan Perikanan Jawa Barat. Nabila has also volunteered with Jabar Bergerak Zillenial and served as Duta Anak Kota Bandung from April 2018 to May 2022. Additionally, experience includes working as a Quality Control Chemist at LPKL PERUMDA Tirtawening Kota Bandung. Nabila holds a D1 degree in Chemist Analysis from SMKN 13 Bandung, completed in May 2022.

Location

Bandung, Indonesia

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


COMBIPHAR

1 followers

Combiphar was founded in 1971 as a pharmaceutical company. Today, Combiphar is transforming into a modern consumer healthcare company that produces and markets more than 200 prescription and over-the-counter quality and affordable products, among others, OBH Combi cough syrup, Insto eye-care solution, JointFit gel-based relief for joints, CombiKid vitamin supplements, Privé green-tea based feminine hygiene wash, and Hezandra hepatoprotector supplement. Equipped with the latest production technology and the most up-to-date professional operation standards, Combiphar’s manufacturing plant, which is located in Padalarang, West Java, has most recently obtained the Therapeutic Goods Administration (TGA) Certification, allowing selected products to be exported to Australia. Additionally, Combiphar also has its own Research & Development facility, focusing on the quality optimization of prescription drugs to ensure that they meet the requirements of Bioavailability and Bioequivalence, as well as in the field of Nanotechnology. Combiphar has recently been ranked 2nd among local pharmaceutical companies recognized as “Indonesia’s Most Reputable Healthcare Brands 2015” (Onbee Research/SWA, May 2015) in terms of brand equity, customer loyalty, and customer experience.